Prognostic factors in diffuse malignant pleural mesothelioma

G. Ak, M. Metintas, S. Metintas, H. Yildirim, S. Erginel, F. Alatas (Eskisehir, Turkey)

Source: Annual Congress 2007 - Pleural malignancy

Session: Pleural malignancy
Session type: Oral Presentation
Number: 4456

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Ak, M. Metintas, S. Metintas, H. Yildirim, S. Erginel, F. Alatas (Eskisehir, Turkey). Prognostic factors in diffuse malignant pleural mesothelioma. Eur Respir J 2007; 30: Suppl. 51, 4456

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines Year: 2009
Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012
Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014
Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016
Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015
Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Clinical and morphological prognostic factors in patients with malignant pleura mesothelioma (MPM) Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Diagnosis of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006
Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 74s Year: 2005
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011
Non-malignant pleural disease from asbestos and malignant pleural mesothelioma Source: Eur Respir Monogr 2020; 89: 141-149 Year: 2020